🟢 Edesa Biotech is trading 6% up in after-hours trading as the specific catalyst remains unclear

Edesa Biotech is trading at $4.24, up 5.81% after hours; its specific catalyst remains unclear.

• Shares fell 4.75% to $4.01 on October 1, after rising 18.26% on September 30.
• No October 1 company announcement was identified; the company’s news page lists its latest release as the August 19 public-offering news.
• Reported broader-market index moves were modest and do not clearly explain the after-hours rise.